Overview
BHVN market data
Price History
BHVN price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$6.86 Diluted earnings per share over the trailing twelve months.
- Beta
- 3.09 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $7.48 – $18.57 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $2.2B · P/B 28.77.
Company News
Morgan Stanley Maintains Overweight on Biohaven, Raises Price Target to $19Benzinga · Aug 12, 2026, 3:38 PM
RBC Capital Maintains Outperform on Biohaven, Raises Price Target to $23Benzinga · Aug 11, 2026, 3:14 PM
Biohaven Q2 Adj. EPS $(0.78) Misses $(0.73) EstimateBenzinga · Aug 10, 2026, 8:41 PM
8-K filing — Biohaven Ltd. (BHVN)SEC EDGAR · Aug 10, 2026, 8:22 PM
Biohaven And Yale University Announce Federal Jury Verdict In Their Favor In Trade Secret Misappropriation And Breach Of Contract Litigation Against Avilar Therapeutics And RA CapitalBenzinga · Jul 27, 2026, 11:08 AM
ManpowerGroup Posts Upbeat Q2 Earnings, Joins Docebo, Zentalis Pharmaceuticals And Other Big Stocks Moving Higher On FridayBenzinga · Jul 17, 2026, 2:09 PM
Biohaven Completes Enrollment In RISE3 Trial To Evaluate Opakalim Channel Activator To Treat Refractory Focal EpilepsyBenzinga · Jun 30, 2026, 11:35 AM
Analyst Warns Biohaven's Lead Drug May Struggle To Stand OutBenzinga · Jun 29, 2026, 6:10 PM
Biohaven, Goodyear Tire And Other Big Stocks Moving Lower In Monday’s Pre-Market SessionBenzinga · Jun 29, 2026, 12:15 PM
B of A Securities Downgrades Biohaven to Underperform, Lowers Price Target to $11Benzinga · Jun 29, 2026, 11:50 AM